Fibromyalgia Syndrome Medication, Drugs & Medicine

Latest Health Related News:
Start Of Phase II Trial Of Intravenous Artesunate For Children With Severe Malaria
A multicentre Phase II trial of intravenous artesunate will begin recruitment of patients in September. The 5.3 M Euro trial, funded by the European and Developing Countries Clinical Trials Partnership (EDCTP), and sponsored by Medicines for Malaria Venture (MMV) will be conducted in Gabon and Malawi. It will evaluate the efficacy of two intravenous artesunate dosing regimens in clearing Plasmodium falciparum parasites in children with severe malaria.
Government Proposals To Prevent Another Training Disaster Inadequate, Warns BMA, UK
Proposals to prevent a repeat of this year's 'MTAS'* medical training disaster are unsatisfactory, the BMA says yesterday. It warns that any computer system to recruit junior doctors in future must be "tested to destruction", and says there should be no limit on the number of applications they can make. The English Department of Health is currently consulting on a new system to select junior doctors for specialist training in England in 2008.
Additional Influenza Vaccine Approved For Upcoming Influenza Season - Approval Increases Available Doses To Record Level
The U.S. Food and Drug Administration approved Afluria, an additional seasonal influenza vaccine for the immunization of people ages 18 and older.Afluria is intended to protect adults from influenza type A and type B flu viruses. Influenza is a contagious respiratory illness that can cause annual epidemics. The approval of Afluria, manufactured by CSL Limited of Parkville, Australia, brings the number of seasonal influenza manufacturers licensed for the U.S.